Armata Pharmaceuticals Inc (ARMP)
2.10
+0.01
(+0.48%)
USD |
NYAM |
Nov 21, 16:00
2.10
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2017 | -11.76K% |
| September 30, 2017 | -2.05K% |
| June 30, 2017 | -23.08K% |
| March 31, 2017 | -11.19K% |
| December 31, 2016 | -43.18K% |
| September 30, 2016 | -8.19K% |
| June 30, 2016 | -3.74K% |
| March 31, 2016 | -2.94K% |
| December 31, 2015 | -1.74K% |
| September 30, 2015 |
| Date | Value |
|---|---|
| June 30, 2015 | |
| March 31, 2015 | -14.21K% |
| December 31, 2014 | -657.4% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | -10.87K% |
| December 31, 2013 | -181.7% |
| September 30, 2013 | |
| June 30, 2013 | -4.66K% |
| March 31, 2013 | -7.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -10.57K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 18.02% |
| Electromed Inc | 10.05% |
| Xtant Medical Holdings Inc | -17.98% |